Genmab A/S Purchase Of Interests In Investments Accounted For Using Equity Method
Genmab A/S (GNMSF) reported Purchase Of Interests In Investments Accounted For Using Equity Method of $4.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod · last filed 2026-02-17
DKK
| Period end | Purchase Of Interests In Investments Accounted For Using Equity Method 6 month | Purchase Of Interests In Investments Accounted For Using Equity Method 12 month |
|---|---|---|
| 2024-12-31 | 55.00M DKK 6-K · filed 2025-02-12 | |
| 2024-06-30 | 33.00M DKK 6-K · filed 2024-08-08 | |
| 2023-12-31 | 31.00M DKK 6-K · filed 2025-02-12 | |
| 2023-06-30 | 15.00M DKK 6-K · filed 2024-08-08 | |
| 2022-12-31 | 39.00M DKK 6-K · filed 2025-02-12 | |
| 2022-06-30 | 22.00M DKK 6-K · filed 2023-08-03 | |
| 2021-12-31 | 102.00M DKK 6-K · filed 2024-02-14 | |
| 2021-06-30 | 92.00M DKK 6-K · filed 2022-08-10 |
USD
| Period end | Purchase Of Interests In Investments Accounted For Using Equity Method 6 month | Purchase Of Interests In Investments Accounted For Using Equity Method 12 month |
|---|---|---|
| 2025-12-31 | $4.00M 20-F · filed 2026-02-17 | |
| 2025-06-30 | $3.00M 6-K · filed 2025-08-07 | |
| 2024-12-31 | $8.00M 20-F · filed 2026-02-17 | |
| 2024-06-30 | $5.00M 6-K · filed 2025-08-07 | |
| 2023-12-31 | $4.00M 20-F · filed 2026-02-17 |